Jones Financial Companies
AMPH icon

Jones Financial Companies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Jones Financial Companies’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Sell
228
-60
-21% -$1.21K ﹤0.01% 4092
2026
Q1 		$5.47K Sell
288
-243
-46% -$5.95K ﹤0.01% 3796
2025
Q4 		$14.2K Buy
531
+164
+45% +$4.22K ﹤0.01% 3075
2025
Q3 		$9.85K Hold
367
– – ﹤0.01% 3086
2025
Q2 		$8.47K Buy
367
+236
+180% +$5.86K ﹤0.01% 2935
2025
Q1 		$3.72K Buy
131
+50
+62% +$1.6K ﹤0.01% 3051
2024
Q4 		$3.01K Sell
81
-47
-37% -$2.15K ﹤0.01% 2903
2024
Q3 		$6.15K Buy
128
+88
+220% +$3.86K ﹤0.01% 2393
2024
Q2 		$1.6K Buy
+40
New +$1.66K ﹤0.01% 2205

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jones Financial Companies's AMPH Position: Q2 2026 in Review

Jones Financial Companies reduced its Amphastar Pharmaceuticals (AMPH) stake by 21% in Q2 2026, selling an estimated $1.21K and leaving 228 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4092.

Jones Financial Companies first reported a position in AMPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $14.2K in Q4 2025. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Jones Financial Companies held 228 shares of Amphastar Pharmaceuticals worth $4.97K as of Q2 2026.
  • Jones Financial Companies sold 60 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4092 holding.
  • Jones Financial Companies first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Amphastar Pharmaceuticals position peaked at $14.2K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.